Patents by Inventor Fabien Faivre

Fabien Faivre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds and their use in preventing or treating bacterial infections
    Patent number: 10722520
    Abstract: A compound of formula (I) or a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: July 28, 2020
    Assignee: MUTABILIS
    Inventors: Julien Barbion, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Fabien Faivre, Rémi Lebel, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le-Strat, Christophe Simon, Chrystelle Oliveira, Géraldine Le Fralliec, Julie Brias, Laurence Farescour, Sophie Vomscheid, Sébastien Richard
  • Heterocyclic compounds and their use in preventing or treating bacterial infections
    Patent number: 10570131
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: February 25, 2020
    Assignee: MUTABILIS
    Inventors: Julie Brias, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Fabien Faivre, Benoît Ledoussal, Frédéric Le Strat, Sébastien Richard, Christophe Simon, Sophie Vomscheid
  • Heterocyclic compounds and their use in preventing or treating bacterial infections
    Patent number: 10501481
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: December 10, 2019
    Assignee: MUTABILIS
    Inventors: Julie Brias, Sophie Chasset, Francis Chevreuil, Nicolas Lecointe, Benôit Ledoussal, Frédéric Le Strat, Sophie Vomscheid, Sébastien Richard, Fabien Faivre, Julien Barbion, Audrey Caravano, Géraldine Le Fralliec, Christophe Simon
  • HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
    Publication number: 20190224210
    Abstract: A compound of formula (I) or a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 25, 2019
    Inventors: Julien BARBION, Audrey CARAVANO, Sophie CHASSET, Francis CHEVREUIL, Fabien FAIVRE, Rémi LEBEL, Nicolas LECOINTE, Benoît LEDOUSSAL, Frédéric LE-STRAT, Christophe SIMON, Chrystelle OLIVEIRA, Géraldine LE FRALLIEC, Julie BRIAS, Laurence FARESCOUR, Sophie VOMSCHEID, Sébastien RICHARD
  • Heteroaromatic derivatives and their use as pharmaceuticals
    Patent number: 10301305
    Abstract: The invention relates to the compounds (I) and their acids and bases salts: wherein: Formula (I) the dotted line indicates a double bond; X is N or C—R1 and Y is N or C—R2, X and Y not being simultaneously N; A is selected from the group consisting of phenyl, naphthyl and (5-11) membered monocyclic or bicyclic unsaturated cycle or heterocycle possibly substituted as defined in the application, and A can also comprise either a further (4-7) membered heterocycle, said heterocycle being a monocycle, fused, saturated or unsaturated, the polycyclic system then comprising up to 14 members and up to 5 heteroatoms selected from N, O and S; B is selected from the group of substituents as defined in the application, or B is a 4 or (6-10) membered mono or bicyclic saturated or unsaturated heterocycle containing 1-3 heteroatoms selected from N, O and S, linked by a carbon atom, and possibly substituted as defined in the application; R1 is Hydrogen or a substituent as defined in the application; R2 is Hydrogen or Halogen;
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: May 28, 2019
    Assignee: MUTABILIS
    Inventors: Dmytro Atamanyuk, Francis Chevreuil, Fabien Faivre, Nicolas Lecointe, Benoît Ledoussal, Chrystelle Oliveira, Christophe Simon, Vincent Gerusz
  • Heterocyclic compounds and their use in preventing or treating bacterial infections
    Patent number: 10183943
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: January 22, 2019
    Assignee: MUTABILIS
    Inventors: Julien Barbion, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le Strat, Sébastien Richard, Christophe Simon, Sophie Vomscheid, Julie Brias, Sophie Briet, Fabien Faivre, Géraldine Le Fralliec, Chrystelle Oliveira
  • Heterocyclic compounds and their use in preventing or treating bacterial infections
    Patent number: 10072006
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: September 11, 2018
    Assignee: MUTABILIS
    Inventors: Audrey Caravano, Sophie Chasset, Francis Chevreuil, Fabien Faivre, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le Strat, Sébastien Richard, Christophe Simon, Sophie Vomscheid, Julie Brias, Julien Barbion
  • Inhibitors of viral replication, their process of preparation and their therapeutical uses
    Patent number: 9994509
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Grant
    Filed: July 7, 2014
    Date of Patent: June 12, 2018
    Assignee: HIVIH
    Inventors: Benoit Ledoussal, Frédéric Le Strat, Sophie Chasset, Julien Barbion, Julie Brias, Audrey Caravano, Fabien Faivre, Sophie Vomscheid
  • HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
    Publication number: 20180118765
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Application
    Filed: April 1, 2016
    Publication date: May 3, 2018
    Inventors: Julie Brias, Sophie Chasset, Francis Chevreuil, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le Strat, Sophie Vomscheid, Sébastien Richard, Fabien Faivre, Julien Barbion, Audrey Caravano, Géraldine Le Fralliec, Christophe Simon
  • Heterocyclic Compounds and Their Use in Preventing or Treating Bacterial Infections
    Publication number: 20180093985
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Application
    Filed: May 6, 2016
    Publication date: April 5, 2018
    Inventors: Julien Barbion, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le Strat, Sébastien Richard, Christophe Simon, Sophie Vomscheid, Julie Brias, Sophie Briet, Fabien Faivre, Géraldine Le Fralliec, Chrystelle Oliveira
  • HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
    Publication number: 20180086760
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Application
    Filed: March 30, 2016
    Publication date: March 29, 2018
    Inventors: Julie Brias, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Fabien Faivre, Benoît Ledoussal, Frédéric Le Strat, Sébastien Richard, Christophe Simon, Sophie Vomscheid
  • NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
    Publication number: 20180086761
    Abstract: The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as ?-lactamase inhibitors and/or as antibacterial agents.
    Type: Application
    Filed: March 30, 2016
    Publication date: March 29, 2018
    Inventors: Audrey Caravano, Sophie Chasset, Francis Chevreuil, Fabien Faivre, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le Strat, Sébastien Richard, Christophe Simon, Sophie Vomscheid, Julie Brias, Julien Barbion
  • HETEROAROMATIC DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
    Publication number: 20170015661
    Abstract: The invention relates to the compounds (I) and their acids and bases salts: wherein: Formula (I) the dotted line indicates a double bond; X is N or C—R1 and Y is N or C—R2, X and Y not being simultaneously N; A is selected from the group consisting of phenyl, naphthyl and (5-11) membered monocyclic or bicyclic unsaturated cycle or heterocycle possibly substituted as defined in the application, and A can also comprise either a further (4-7) membered heterocycle, said heterocycle being a monocycle, fused, saturated or unsaturated, the polycyclic system then comprising up to 14 members and up to 5 heteroatoms selected from N, O and S; B is selected from the group of substituents as defined in the application, or B is a 4 or (6-10) membered mono or bicyclic saturated or unsaturated heterocycle containing 1-3 heteroatoms selected from N, O and S, linked by a carbon atom, and possibly substituted as defined in the application; R1 is Hydrogen or a substituent as defined in the application; R2 is Hydrogen or Halogen;
    Type: Application
    Filed: February 24, 2015
    Publication date: January 19, 2017
    Inventors: Dmytro ATAMANYUK, Francis CHEVREUIL, Fabien FAIVRE, Nicolas LECOINTE, BenoÏ LEDOUSSAL, Chrystelle OLIVEIRA, Christophe SIMON
  • Inhibitors of viral replication, their process of preparation and their therapeutical uses
    Publication number: 20160152543
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Application
    Filed: July 7, 2014
    Publication date: June 2, 2016
    Applicant: LABORATOIRE BIODIM
    Inventors: Benoit LEDOUSSAL, Frédéric LE STRAT, Sophie CHASSET, Julien BARBION, Julie BRIAS, Audrey CARAVANO, Fabien FAIVRE, Sophie VOMSCHEID
  • Antibacterial hydroxyphenyl compound
    Patent number: 9272985
    Abstract: The invention relates to a novel hydroxyphenyl compound, to the preparation of the compound and intermediates used therein, to the use of the compound as an antibacterial medicament and pharmaceutical compositions containing the compound.
    Type: Grant
    Filed: November 11, 2009
    Date of Patent: March 1, 2016
    Assignee: FAB PHARMA S.A.S.
    Inventors: Vincent Gerusz, Fabien Faivre, Mayalen Oxoby, Alexis Denis, Yannick Bonvin
  • NOVEL ANTIBACTERIAL HYDROXYPHENYL COMPOUND
    Publication number: 20120232155
    Abstract: The invention relates to a novel hydroxyphenyl compound, to the preparation of the compound and intermediates used therein, to the use of the compound as an antibacterial medicament and pharmaceutical compositions containing the compound.
    Type: Application
    Filed: November 11, 2009
    Publication date: September 13, 2012
    Inventors: Vincent Gerusz, Fabien Faivre, Mayalen Oxoby, Alexis Denis, Yannick Bonvin